Efficacy and Safety of Botulinum Toxin Type A (NABOTA) for Post-stroke Upper Extremity Spasticity: A Multicenter Phase IV Trial

OBJECTIVE: To evaluate the efficacy and safety of Daewoong botulinum toxin type A (NABOTA) after its launch in South Korea. METHODS: This prospective, multicenter, open-label phase IV clinical trial included 222 patients with stroke. All patients visited the clinic at baseline and at weeks 4, 8, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Wonjae, Kang, Seong Min, Lee, Sang Yoon, Seo, Han Gil, Park, Yoon Ghil, Kwon, Bum Sun, Lee, Kwang Jae, Kim, Deog Young, Kim, Hyoung Seop, Lee, Shi-Uk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Academy of Rehabilitation Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452292/
https://www.ncbi.nlm.nih.gov/pubmed/36070998
http://dx.doi.org/10.5535/arm.22061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452292/
https://www.ncbi.nlm.nih.gov/pubmed/36070998
http://dx.doi.org/10.5535/arm.22061

Ejemplares similares